BLOG

Patent analysis and insight

Analysis and insight to bring more predictability, transparency, and equity to your patent prosecution.

Posts about

BI

The Future of Pharma: The AstraZeneca / Gilead Merger

In early June, AstraZeneca approached rival drugmaker Gilead Sciences to discuss a potential merger. Though some doubt the feasibility of such a deal, this would be the biggest healthcare merger on record.

Read More

Future of Transportation: The Fiat Chrysler / Peugeot Merger

Fiat Chrysler and Peugeot owner PSA Group recently announced the terms of a $48 billion merger that would create the world's fourth-largest automaker. A primary reason for the merger is to share the cost of developing electric and autonomous vehicles.

Read More
Pfizer Mylan Header

Future of Pharma: The Pfizer / Mylan Merger

Pfizer and Mylan, the maker of EpiPens, are merging. Pfizer will offload Upjohn, its portfolio of drugs that are no longer protected by patents, including Viagra, Lipitor and Celebrex, combining with rival Mylan to create a new company that will have a new, yet-to-be-announced name.

Read More
Oscar _ Movie Post

Lights, Camera, (Office) Action: Patents + the Film Industry

On Sunday, February 24, film fans, pop culture fanatics, and all of Hollywood’s brightest stars will tune in to the live broadcast of the 91st Oscars ceremony. With eight movies nominated for best picture, from the bombastic Queen biopic Bohemian Rhapsody to the devastatingly poetic Roma, the ceremony is guaranteed to be star-studded, ornate, and maybe even a little unpredictable.

Read More

Are you ready to transform your patent practice?

Patent prosecution is complex – we know. If you’re ready for simpler workflows and more predictable outcomes, give us a call.